PCC Rokita Management
Management criteria checks 3/4
PCC Rokita's CEO is Wieslaw Klimkowski, appointed in Jan 2005, has a tenure of 19.83 years. total yearly compensation is PLN20.28M, comprised of 14.1% salary and 85.9% bonuses, including company stock and options. directly owns 0.5% of the company’s shares, worth PLN7.09M. The average tenure of the management team and the board of directors is 14.8 years and 8.8 years respectively.
Key information
Wieslaw Klimkowski
Chief executive officer
zł20.3m
Total compensation
| CEO salary percentage | 14.1% |
| CEO tenure | 19.8yrs |
| CEO ownership | 0.5% |
| Management average tenure | 14.8yrs |
| Board average tenure | 8.8yrs |
Recent management updates
Recent updates
Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?
May 30
Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Aug 24PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 29Is PCC Rokita (WSE:PCR) A Risky Investment?
Jan 18PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23
Apr 16Why We Like The Returns At PCC Rokita (WSE:PCR)
Mar 19What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?
Jan 25We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)
Sep 01Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching
Jun 14Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?
May 18Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes
Apr 13Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem
Mar 23PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Mar 09Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?
Feb 19
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?
Feb 04Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Jan 15Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?
Dec 30Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years
Dec 17PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 03Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?
Nov 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | zł121m |
| Jun 30 2024 | n/a | n/a | zł158m |
| Mar 31 2024 | n/a | n/a | zł144m |
| Dec 31 2023 | zł20m | zł3m | zł268m |
| Sep 30 2023 | n/a | n/a | zł473m |
| Jun 30 2023 | n/a | n/a | zł589m |
| Mar 31 2023 | n/a | n/a | zł692m |
| Dec 31 2022 | zł43m | zł2m | zł675m |
| Sep 30 2022 | n/a | n/a | zł569m |
| Jun 30 2022 | n/a | n/a | zł499m |
| Mar 31 2022 | n/a | n/a | zł472m |
| Dec 31 2021 | zł10m | zł826k | zł417m |
| Sep 30 2021 | n/a | n/a | zł294m |
| Jun 30 2021 | n/a | n/a | zł247m |
| Mar 31 2021 | n/a | n/a | zł171m |
| Dec 31 2020 | zł5m | zł573k | zł117m |
| Sep 30 2020 | n/a | n/a | zł73m |
| Jun 30 2020 | n/a | n/a | zł82m |
| Mar 31 2020 | n/a | n/a | zł72m |
| Dec 31 2019 | zł4m | zł563k | zł93m |
| Sep 30 2019 | n/a | n/a | zł145m |
| Jun 30 2019 | n/a | n/a | zł160m |
| Mar 31 2019 | n/a | n/a | zł201m |
| Dec 31 2018 | zł4m | zł838k | zł227m |
| Sep 30 2018 | n/a | n/a | zł243m |
| Jun 30 2018 | n/a | n/a | zł215m |
| Mar 31 2018 | n/a | n/a | zł213m |
| Dec 31 2017 | zł2m | zł314k | zł182m |
Compensation vs Market: Wieslaw's total compensation ($USD4.91M) is above average for companies of similar size in the Polish market ($USD686.81K).
Compensation vs Earnings: Wieslaw's compensation has been consistent with company performance over the past year.
CEO
Wieslaw Klimkowski
19.8yrs
Tenure
zł20,278,000
Compensation
Mr. Wieslaw Klimkowski serves as the President of the Management Boards at Rokita S.A. and Silesia-Kalk Sp. z o.o. Mr. Klimkowski served as Director of Investor Supervision & Group Development of PCC Rokit...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President of the Management & General Director | 19.8yrs | zł20.28m | 0.50% PLN 7.1m | |
| Vice President of the Management Board & Financial Director | 14.8yrs | zł16.59m | 0.34% PLN 4.7m | |
| Secretary of the Supervisory Board & Independent Member of Supervisory Board | 10yrs | zł207.00k | no data | |
| Chief Accountant | no data | no data | no data |
14.8yrs
Average Tenure
Experienced Management: PCR's management team is seasoned and experienced (14.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Secretary of the Supervisory Board & Independent Member of Supervisory Board | 8.7yrs | zł207.00k | no data | |
| Chairman of the Supervisory Board | 12.5yrs | no data | no data | |
| Deputy Chairman of Supervisory Board | 12.5yrs | no data | no data | |
| Member of Supervisory Board | 8.8yrs | zł204.00k | no data | |
| Independent Member of Supervisory Board | 7.8yrs | zł307.00k | no data |
8.8yrs
Average Tenure
Experienced Board: PCR's board of directors are considered experienced (8.8 years average tenure).